REG-Elan Corporation PLC Elan Announces Availability of Information Statement in Respect of Prothena Corporation plc

Thu Dec 20, 2012 2:00am EST

* Reuters is not responsible for the content in this press release.

DUBLIN--(Business Wire)--

Elan Corporation, plc (NYSE: ELN) announces that the information statement in
respect of Prothena Corporation plc, which is being provided to holders of
record of Elan ordinary shares and ADSs as of December 14, 2012 and which
describes the separation and distribution of the Prothena Business in detail and
contains important business and financial information about Prothena, has been
published. The information statement is now available on Elan`s website at 

About Elan

Elan Corporation, plc (NYSE: ELN) is a neuroscience-based biotechnology company
committed to making a difference in the lives of patients and their families by
dedicating itself to bringing innovations in science to fill significant unmet
medical needs that continue to exist around the world. Elan shares trade on the
New York and Irish Stock Exchanges. For additional information about the
Company, please visit 

Elan Corporation, plc
Investor Relations:
Chris Burns, 800-252-3526
David Marshall, 353-1-709-4444
Media Relations:
Emer Reynolds, + 353-1-709-4022
Jonathan Birt, +44-751-559-7858

Elan Corporation PLC 

Copyright Business Wire 2012